Adipotide

FDA APPROVAL PENDING

Phase 1

Weight

Adipotide

Proapoptotic Peptidomimetic | Targeted Fat Loss

Learn more

Weight

Adipotide

Amino acid sequence

25

Amino acids

2611.41da

Molecular weight

Peptide

Type

Adipotide (also known as FTPP or Prohibitin-Targeting Peptide-1) is a bipartite peptidomimetic that selectively destroys the blood vessels supplying white adipose tissue, causing fat cell death through ischemia-induced apoptosis. It targets prohibitin and annexin A2 receptors expressed on white adipose vasculature, distinguishing it from hormonal or metabolic weight-loss agents. It has been studied in obese rodent and primate models with dramatic fat-loss results, and entered Phase 1 clinical trials in 2012, though development was subsequently discontinued due to renal toxicity concerns.

Top researched benefits

Overview of Adipotide

Adipotide's homing sequence (CKGGRAKDC) binds to prohibitin and annexin A2 receptors on endothelial cells of white adipose tissue vasculature, after which its proapoptotic D(KLAKLAK)2 domain disrupts mitochondrial membranes, triggering targeted apoptosis of the feeding vasculature and causing ischemic death of downstream white adipocytes.

weight loss

  • Selective white adipose tissue vascular targeting produced 7-15% body-weight loss over 4 weeks in obese macaques.

metabolic

  • Improved insulin response (reduced insulin AUC) following fat-mass reduction in primates.

appetite control

  • Weight loss without primary appetite suppression; peripheral vascular approach.

Typical Dose

250–1000mcg per injection, titrated up over cycle

Frequency

once daily subcutaneous injection

Cycle Duration

4–8 week cycle with gradual dose escalation

Storage

Lyophilized: -20°C long-term (up to 2 years) or 2–8°C short-term (up to 3 months). Reconstituted: refrigerate at 2–8°C, use within 14 days, avoid freeze-thaw cycles.

Chemical Makeup

Key benefits

Selective destruction of white adipose tissue vasculature leading to targeted fat cell apoptosis without affecting lean tissue

Produced approximately 11% body weight reduction in obese rhesus monkeys after 28 days of treatment

Caused up to 30% body weight reduction in obese rodent models over a 4-week treatment period

Significantly improved insulin sensitivity and reduced insulinogenic index in obese primate models within days of treatment onset

Community interest

This peptide is still gaining traction in the community.

Proapoptotic Peptidomimetic | Targeted Fat Loss

This overview is informational and based on aggregated descriptions from studies and user reports.

Was it helpful?Yes
No

Adipotide Molecular Information

View the scientifc details of Adipotide.

25

Amino Acids

Adipotide

Cys

Cys

Position 1

Lys

Lys

Position 2

Gly

Gly

Position 3

Gly

Gly

Position 4

Arg

Arg

Position 5

Ala

Ala

Position 6

Lys

Lys

Position 7

Asp

Asp

Position 8

Cys

Cys

Position 9

Gly

Gly

Position 10

Gly

Gly

Position 11

Lys

Lys

Position 12

Leu

Leu

Position 13

Ala

Ala

Position 14

Lys

Lys

Position 15

Leu

Leu

Position 16

Ala

Ala

Position 17

Lys

Lys

Position 18

Lys

Lys

Position 19

Leu

Leu

Position 20

Ala

Ala

Position 21

Lys

Lys

Position 22

Leu

Leu

Position 23

Ala

Ala

Position 24

Lys

Lys

Position 25

Amino acid sequence
CysteinePosition 1
LysinePosition 2
GlycinePosition 3
GlycinePosition 4
ArgininePosition 5
AlaninePosition 6
LysinePosition 7
Aspartic acidPosition 8
CysteinePosition 9
GlycinePosition 10
GlycinePosition 11
LysinePosition 12
LeucinePosition 13
AlaninePosition 14
LysinePosition 15
LeucinePosition 16
AlaninePosition 17
LysinePosition 18
LysinePosition 19
LeucinePosition 20
AlaninePosition 21
LysinePosition 22
LeucinePosition 23
AlaninePosition 24
LysinePosition 25

Molecular Weight

2611.41Da

Chain Length

25Amino Acids

Type

Peptide

Adipotide Protocols

Subcutaneous injection is the primary and only research-validated delivery route for Adipotide (FTPP), used in all primate and rodent preclinical fat-loss studies. Injections are administered once daily into abdominal subcutaneous fat, targeting prohibitin receptors on white adipose vasculature; adequate daily hydration is essential throughout any cycle to support renal clearance and reduce nephrotoxicity risk.

GoalDosageFrequencyRoute
Fat loss — conservative titration start2501 day rangeSubQ
Fat loss — moderate titration5001 day rangeSubQ
Fat loss — advanced titration7501 day rangeSubQ
Fat loss — peak flat dose10001 day rangeSubQ
Fat loss — primate standard dose (0.25 mg/kg, reference 80 kg body weight)200001 day rangeSubQ
Fat loss — primate advanced dose (0.43 mg/kg, reference 80 kg body weight)344001 day rangeSubQ

Reconstitution Instructions

Materials needed:

Adipotide lyophilized powder vial (10 mg)Bacteriostatic water (BAC water), 3.0 mL per vialInsulin syringes (0.5–1 mL, 29–31 gauge, 4–6 mm needle length)Drawing needle (18–21 gauge) for reconstitutionAlcohol swabsRefrigerator for storage at 2–8 °C

Steps to reconstitute

  1. Allow the lyophilized Adipotide vial to reach room temperature before reconstitution (approximately 15–20 minutes out of the freezer)
  2. Draw 3.0 mL of bacteriostatic water (BAC water) into a sterile drawing syringe
  3. Insert the drawing needle through the vial stopper and inject the BAC water slowly down the inside wall of the vial — do not aim the stream directly onto the powder
  4. Gently swirl or roll the vial between your palms until the powder is fully dissolved — do not shake the vial, as shaking can degrade the peptide
  5. Label the vial with the reconstitution date; refrigerate at 2–8 °C upright and use within 14 days
  6. Calculate your dose volume: a 10 mg vial reconstituted with 3.0 mL yields a concentration of 3.33 mg/mL (3,333 mcg/mL)
  7. Draw the calculated dose into an insulin syringe, tap to raise air bubbles, and gently depress the plunger to expel them
  8. Clean the injection site (abdomen 2 inches from the navel preferred) with an alcohol swab and allow the skin to dry fully
  9. Pinch the skin to raise a fold, insert the needle at a 45-degree angle into the subcutaneous fat layer, and inject slowly and steadily without aspirating
  10. Withdraw the needle smoothly and apply gentle pressure with a clean swab — do not rub the site
  11. Rotate injection sites systematically across the abdomen, thighs, and upper arms every 3–4 injections to prevent local tissue damage

Adipotide Cycle

The Adipotide Cycle section explains how long a typical cycle lasts and what to expect during each phase. Over time, your body can become less responsive with continuous use.

Taking breaks between cycles may help maintain effectiveness and support better overall results.

Week 1-2
Early reduction in abdominal circumference
Week 2-4
Progressive weight/fat-mass decline
Week 0-0
Partial rebound possible; lab signals include mild creatinine rise and electrolyte shifts

Dosing tools

Adipotide Peptide Dosage Calculator

Calculate peptide doses with our visual syringe guide.

mg

Enter the total amount of peptide in the vial in milligrams (as stated on the label).

The dose you want to inject per administration, in mcg or mg.

1,000 mcg = 1 mg

1 mL

2 mL

3 mL

5 mL

Custom

Volume of bacteriostatic water you add to reconstitute the powder. Use BAC water for preservation.

Injection Results

Based on your vial and dilution inputs.

Adipotide

SINGLE COMPOUND

Volume per injection

0.05

mL

Concentration

10.00

mg/mL

Doses per vial

20

doses

Total injections per vial

20 injections

How it works

Based on a 10 mg Adipotide vial diluted with 1 mL of bacteriostatic water, each 500 mcg injection equals 0.05 mL.

1mL / 100 units

5 units

0.050 mL

Reference Guide

Dosing Cycle

Peptide
Adipotide
Dosing
250–1000mcg per injection, titrated up over cycle
Dosing Frequency
once daily subcutaneous injection
Cycle Duration
4–8 week cycle with gradual dose escalation
Storage
Lyophilized: -20°C long-term (up to 2 years) or 2–8°C short-term (up to 3 months). Reconstituted: refrigerate at 2–8°C, use within 14 days, avoid freeze-thaw cycles.

Note: Triple agonist; microdose for fewer side effects

Reconstitution Tips

  • Use bacteriostatic water (BAC)contains 0.9% benzyl alcohol for preservation
  • Inject water slowlyaim down the vial wall, not directly onto powder
  • Never shakegently swirl or roll the vial until dissolved
  • Store properlyrefrigerate at 2-8°C after reconstitution
  • Use within 28 daysmost reconstituted peptides remain stable for about 4 weeks
  • Keep sterilealways clean vial tops with alcohol before drawing

Peptide Interactions

Research suggestions of Adipotide interactions with other common peptides and substances.

Weight

aod

Metabolic

AOD-9604

MONITOR

No published data on combined use or pharmacodynamic interaction.

MONITOR

Healing

bpc

Longevity

BPC-157

COMPATIBLE

No known direct interaction; distinct mechanisms and targets.

COMPATIBLE

Weight

cag

Metabolic

Cagrilintide

MONITOR

No clinical data on co-administration; mechanisms differ.

MONITOR

Skin

mela

Sexual

Melanotan II

MONITOR

Theoretical vascular/pressor effects; stagger dosing, monitor BP and hydration.

MONITOR

Weight

GLP-1

Metabolic

GLP-1

MONITOR

Potential additive dehydration/GI effects; monitor renal function.

MONITOR

Side effects

Monitor: Be careful when combining Adipotide with AOD-9604, Cagrilintide, Melanotan II, GLP-1.

Contraindications

Pregnancy/lactation (not studied)

Dehydration

Concurrent nephrotoxic medications

Stop signs

Sustained creatinine elevation or oliguria

Progressive electrolyte abnormalities

Severe injection-site reactions or systemic symptoms

Unexpected toxicity

Bad signs

Collapsed/moist cake suggests temperature excursion; do not use without QCCloudiness/precipitate indicates degradation or contamination—discard
Was it helpful?Yes
No

Comments

0.0

0 reviews

5

4

3

2

1

No comments yet

Be the first to share your experience. Your review helps others make more informed decisions.

Frequently asked questions

What is a peptide dosage calculator?

A peptide dosage calculator is a free tool that converts your vial size, bacteriostatic water volume, and target dose into an exact syringe draw volume. Instead of doing the reconstitution math by hand, you enter three inputs and instantly get the concentration of your solution and how many milliliters or syringeunits to draw. This calculator works for single peptide compounds and multi-peptide blends.

How do I calculate peptide dosage from a vial?

To calculate your peptide dose, divide the total peptide content of your vial in micrograms by the volume of bacteriostatic water you added in milliliters. This gives you your solution concentration in mcg/mL. Then divide your target dose by that concentration to get your draw volume. For example, a 5mg (5,000 mcg) vial reconstituted with 2mL of BAC water gives a concentration of 2,500 mcg/mL. A 250 mcg dose would require drawing 0.1mL. This calculator automates all of those steps instantly.

How much Bacteriostatic water should I add to a peptide vial?

Most people add 2mL to 3mL of bacteriostatic water per vial, but the right amount depends on the dose you want to draw and the syringe size you are using. Adding 1mL to a 5mg vial gives you a concentration of 5,000 mcg/mL, making each dose very small in volume. Adding 2mL gives you 2,500 mcg/mL, which is easier to measure on a standard insulin syringe. A general guideline is to choose a volume that puts your typical dose somewhere between 10 and 30 units on a U-100 syringe. Use the calculator above to test different water volumes and find what works for your dose.

How are peptides different from proteins?

Both are made of amino acids, but peptides are much smaller than proteins. Because of their tiny size, peptides can act like tiny messengers in the body, sending specific signals to your cells to tell them exactly what to do.​

AdipotideResearch References

Adipotide is a phase 1 compound

4Research references

Adipotide

Adipotide is a phase 1 compound

A peptidomimetic targeting white fat causes weight loss and improved insulin resistance in obese monkeys

Rhesus macaques at 0.43 mg/kg SC daily for 28 days showed 7.4-14.7% weight loss; insulin resistance improved; mild, dose-dependent, reversible proximal tubule changes.

2011

Reversal of obesity by targeted ablation of adipose tissue

Mice with diet-induced obesity showed ~30% weight reduction; adipose vascular apoptosis; metabolic normalization.

2004

Prohibitin/Annexin A2 Interaction Regulates Fatty-Acid Transport

Mechanistic validation of prohibitin/ANXA2 axis in adipose tissue, core to TP01 targeting.

2016

Mixed-Chirality Prohibitin Peptide: D-(RLARLAR)2 Enhances Stability

Next-generation prohibitin constructs improve serum stability and efficacy vs. first-generation TP01.

2025

Calculate peptide dosages

Learning how to calculate a peptide dose? Use our beginner-friendly peptide dosage, blend, and accumulation calculators. Enter vial size, reconstitution volume, and target dose to get exact draw volumes instantly. No guesswork, just clear guidance that helps prevent common mistakes.